We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+0.77%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
AUM
$6.59B
AUM Growth
+$145M
Cap. Flow
+$109M
Cap. Flow %
1.66%
Top 10 Hldgs %
31.76%
Holding
2,210
New
172
Increased
631
Reduced
693
Closed
122

Sector Composition

Rank Sector Weight
1 Technology 11.46%
2 Financials 6.86%
3 Industrials 5.05%
4 Healthcare 3.76%
5 Consumer Discretionary 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPH icon
1751
Amphastar Pharmaceuticals
AMPH
$825M
$4.01K ﹤0.01%
108
FTRE icon
1752
Fortrea Holdings
FTRE
$1.85B
$4.01K ﹤0.01%
215
CNRG icon
1753
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$200M
$4K ﹤0.01%
66
ALKS icon
1754
Alkermes
ALKS
$8.82B
$3.97K ﹤0.01%
138
KNF icon
1755
Knife River
KNF
$4.43B
$3.96K ﹤0.01%
39
UFPI icon
1756
UFP Industries
UFPI
$4.97B
$3.94K ﹤0.01%
+35
New +$4.51K
LEVI icon
1757
Levi Strauss
LEVI
$9.44B
$3.89K ﹤0.01%
225
DRS icon
1758
Leonardo DRS
DRS
$12.8B
$3.88K ﹤0.01%
120
EFG icon
1759
iShares MSCI EAFE Growth ETF
EFG
$16.3B
$3.87K ﹤0.01%
40
+19
+90% +$1.93K
XSOE icon
1760
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.03B
$3.87K ﹤0.01%
127
TREX icon
1761
Trex
TREX
$4.51B
$3.87K ﹤0.01%
56
+36
+180% +$2.54K
MKTX icon
1762
MarketAxess Holdings
MKTX
$4.15B
$3.85K ﹤0.01%
17
DSGN icon
1763
Design Therapeutics
DSGN
$736M
$3.76K ﹤0.01%
610
KRYS icon
1764
Krystal Biotech
KRYS
$9.88B
$3.76K ﹤0.01%
24
-15
-38% -$2.66K
SNV
1765
DELISTED
Synovus
SNV
$3.74K ﹤0.01%
73
ATXS
1766
DELISTED
Astria Therapeutics
ATXS
$3.72K ﹤0.01%
416
ARKQ icon
1767
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.88B
$3.71K ﹤0.01%
+48
New +$3.34K
CRDO icon
1768
Credo Technology Group
CRDO
$39.7B
$3.7K ﹤0.01%
+55
New +$2.73K
PTC icon
1769
PTC
PTC
$13.7B
$3.68K ﹤0.01%
20
-315
-94% -$59.7K
RBLX icon
1770
Roblox
RBLX
$34B
$3.65K ﹤0.01%
63
RDVT icon
1771
Red Violet
RDVT
$859M
$3.62K ﹤0.01%
100
NUVL
1772
DELISTED
Nuvalent
NUVL
$3.6K ﹤0.01%
+46
New +$4.3K
CLBT icon
1773
Cellebrite
CLBT
$3.54B
$3.55K ﹤0.01%
+161
New +$3.1K
UAA icon
1774
Under Armour
UAA
$3B
$3.47K ﹤0.01%
419
+8
+2% +$73
AAL icon
1775
American Airlines Group
AAL
$9.58B
$3.45K ﹤0.01%
198
+6
+3% +$86

Similar funds

Clearstead Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Clearstead Advisors held 2,210 positions worth $6.59B, up 2.3% from $6.45B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Clearstead Advisors's Q4 2024 filing shows 172 new, 631 increased, 693 reduced and 122 closed positions. Its largest new stake was Albertsons Companies: 484,880 shares worth $9.52M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $24.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.

  • Clearstead Advisors's largest Q4 2024 buy was Albertsons Companies: 484,880 shares worth $9.52M.
  • Clearstead Advisors added most to Vanguard Mortgage-Backed Securities ETF in Q4 2024, an estimated $69.9M increase.
  • Clearstead Advisors's biggest Q4 2024 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $24.2M.
  • Clearstead Advisors fully exited Innovator US Equity Power Buffer ETF January in Q4 2024, selling an estimated $1.1M.
  • Clearstead Advisors's ten largest holdings make up 32% of its $6.59B portfolio in Q4 2024.
  • Clearstead Advisors opened 172 new positions and closed 122 in Q4 2024.
  • Clearstead Advisors's portfolio value rose 2.3% quarter-over-quarter to $6.59B.

Based on Clearstead Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.